Qiu MZ - Search Results

1

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature.

Xu JY, Guan WL, Lu SX, Wei XL, Shi WJ, Ren C, Li YH, Li SP, Qiu MZ, Wang FH. Xu JY, et al. Among authors: qiu mz. Clin Med Insights Oncol. 2022 Apr 30;16:11795549221090186. doi: 10.1177/11795549221090186. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35509769 Free PMC article.

2

A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.

Luo HY, Xu RH, Zhang L, Li YH, Shi YX, Lin TY, Han B, Wang F, Qiu MZ, He YJ, Guan ZZ. Luo HY, et al. Among authors: qiu mz. Chemotherapy. 2008;54(3):228-35. doi: 10.1159/000140467. Epub 2008 Jun 18. Chemotherapy. 2008. PMID: 18560231 Clinical Trial.

3

[Prognosis of 84 intrahepatic cholangiocarcinoma patients].

Li FH, Chen XQ, Luo HY, Li YH, Wang F, Qiu MZ, Teng KY, Li ZH, Xu RH. Li FH, et al. Among authors: qiu mz. Ai Zheng. 2009 May;28(5):528-32. Ai Zheng. 2009. PMID: 19624884 Free article. Chinese.

4

[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].

Qiu MZ, Teng KY, Ruan DY, Li YH, Chen XQ, Pan ZZ, He YJ, Wan DS, Xu RH. Qiu MZ, et al. Ai Zheng. 2009 Jul;28(7):743-8. doi: 10.5732/cjc.008.10815. Ai Zheng. 2009. PMID: 19624903 Free article. Chinese.

5

Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma.

Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, Li YH, Zhou ZW, He YJ, Xu RH. Qiu MZ, et al. Int J Biol Markers. 2009 Oct-Dec;24(4):258-64. doi: 10.1177/172460080902400407. Int J Biol Markers. 2009. PMID: 20082274 Free article.

6

Impact of pretreatment hematologic profile on survival of colorectal cancer patients.

Qiu MZ, Yuan ZY, Luo HY, Ruan DY, Wang ZQ, Wang FH, Li YH, Xu RH. Qiu MZ, et al. Tumour Biol. 2010 Aug;31(4):255-60. doi: 10.1007/s13277-010-0024-x. Epub 2010 Mar 25. Tumour Biol. 2010. PMID: 20336401

7

Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

Luo HY, Xu RH, Wang F, Qiu MZ, Li YH, Li FH, Zhou ZW, Chen XQ. Luo HY, et al. Among authors: qiu mz. Chemotherapy. 2010;56(2):94-100. doi: 10.1159/000305256. Epub 2010 Mar 30. Chemotherapy. 2010. PMID: 20357440 Clinical Trial.

8

Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines.

Luo HY, Wei W, Shi YX, Chen XQ, Li YH, Wang F, Qiu MZ, Li FH, Yan SL, Zeng MS, Huang P, Xu RH. Luo HY, et al. Among authors: qiu mz. Oncol Rep. 2010 Jun;23(6):1735-45. doi: 10.3892/or_00000819. Oncol Rep. 2010. PMID: 20428833

9

Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China.

Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, Teng KY, Wang ZQ, Li YH, Jiang WQ. Qiu MZ, et al. Tumour Biol. 2010 Dec;31(6):633-41. doi: 10.1007/s13277-010-0079-8. Epub 2010 Jul 23. Tumour Biol. 2010. PMID: 20652781

10

Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.

Qiu MZ, Han B, Luo HY, Zhou ZW, Wang ZQ, Wang FH, Li YH, Xu RH. Qiu MZ, et al. Tumour Biol. 2011 Feb;32(1):159-66. doi: 10.1007/s13277-010-0109-6. Epub 2010 Sep 16. Tumour Biol. 2011. PMID: 20845004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters